Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism
- PMID: 22689209
- DOI: 10.1055/s-0032-1314786
Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism
Abstract
For the diagnosis of primary aldosteronism (PA), confirmatory testing is mandatory and different function tests can be employed. There are, however, sparse data comparing the fludrocortisone suppression test (FST) and the saline infusion test (SIT). Patients with PA (n=90) or essential hypertension (n=65) were studied. They underwent one or the other test or both of them. Using the DPC Siemens aldosterone radioimmunoassay, we found that the SIT led to a stronger suppression of aldosterone than the FST. Post-test aldosterone-to-renin ratios (ARRs) and the percentage of suppression of aldosterone serum concentrations performed worse. The same results were observed in patients who underwent both FST and SIT. Some patients had divergent results in both tests. For the SIT, a lower cutoff value should be used than for the FST for the adequate identification of patients with unilateral PA. Long-term prospective studies are needed to address the question at what cutoff values patients benefit from subtype differentiation of PA. We discuss here possible explanations for divergent results obtained with both tests.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Comparison of confirmatory tests for the diagnosis of primary aldosteronism.J Clin Endocrinol Metab. 2006 Jul;91(7):2618-23. doi: 10.1210/jc.2006-0078. Epub 2006 May 2. J Clin Endocrinol Metab. 2006. PMID: 16670162
-
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.J Hypertens. 2007 Jul;25(7):1433-42. doi: 10.1097/HJH.0b013e328126856e. J Hypertens. 2007. PMID: 17563566 Clinical Trial.
-
Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.Scand J Clin Lab Invest. 2009;69(2):234-41. doi: 10.1080/00365510802483690. Scand J Clin Lab Invest. 2009. PMID: 18951242
-
Confirmatory tests in the diagnosis of primary aldosteronism.Horm Metab Res. 2010 Jun;42(6):406-10. doi: 10.1055/s-0029-1246186. Epub 2010 Jan 29. Horm Metab Res. 2010. PMID: 20119882 Review.
-
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.Ann Endocrinol (Paris). 2016 Jul;77(3):202-7. doi: 10.1016/j.ando.2016.01.007. Epub 2016 Jun 16. Ann Endocrinol (Paris). 2016. PMID: 27318644
Cited by
-
Aldosterone-Mediated Sodium Retention Is Reflected by the Serum Sodium to Urinary Sodium to (Serum Potassium)2 to Urinary Potassium (SUSPPUP) Index.Diagnostics (Basel). 2020 Jul 30;10(8):545. doi: 10.3390/diagnostics10080545. Diagnostics (Basel). 2020. PMID: 32751768 Free PMC article.
-
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS.Eur J Endocrinol. 2021 Jan;184(1):167-178. doi: 10.1530/EJE-20-0073. Eur J Endocrinol. 2021. PMID: 33112272 Free PMC article.
-
Efficacy of Oral Furosemide Test for Primary Aldosteronism Diagnosis.J Endocr Soc. 2023 Nov 24;8(1):bvad147. doi: 10.1210/jendso/bvad147. eCollection 2023 Dec 1. J Endocr Soc. 2023. PMID: 38075562 Free PMC article.
-
Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis.Hypertension. 2022 Aug;79(8):1835-1844. doi: 10.1161/HYPERTENSIONAHA.122.19377. Epub 2022 Jun 2. Hypertension. 2022. PMID: 35652330 Free PMC article.
-
Aldosterone excess and resistant hypertension: investigation and treatment.Curr Hypertens Rep. 2014 Jul;16(7):439. doi: 10.1007/s11906-014-0439-7. Curr Hypertens Rep. 2014. PMID: 24792091 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous